ArticleBiomedical engineering letters2025
Optimized multi-stage network with multi-dimensional spatiotemporal interactions for septal and apical hypertrophic cardiomyopathy classification using 12-lead ECGs.
Article in Biomedical engineering letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Hypertrophic cardiomyopathy (HCM) is a common hereditary heart disease and is the leading cause of sudden cardiac death in adolescents. Septal hypertrophy (SH) and apical hypertrophy (AH) are two common types. The former is characterized by abnormal septal myocardial thickening and the latter by left ventricular apical hypertrophy, both of which significantly increase the risk of heart failure, arrhythmias, and other serious complications. Identifying hypertrophic sites in HCM patients using 12-lead electrocardiography (ECG) is crucial for early diagnosis, staging, and prognosis. However, most deep learning methods rely on 1D one-dimensional ECG signal detection, or 2D two-dimensional ECG image or spectrogram recognition, which may result in the loss of spatial or temporal information, thus limiting diagnostic accuracy. Therefore, an optimized multi-stage network with multi-dimensional spatiotemporal interactions (Ms-MdST) is proposed for detecting AH and SH in HCM. The optimized Ms-MdST model combines the advantages of different dimensional convolutions to capture the spatiotemporal characteristics of ECG and consists of a 1D convolution branch for overall temporal features and a 2D convolution branch for similar spatial features across multiple leads. Moreover, a global-local interactive attention mechanism (GLIA) and a multi-loss joint optimization strategy are employed to facilitate multi-stage multi-scale feature fusion. Experimental results show that Ms-MdST achieves F1-scores of 0.9672, 0.7250, and 0.8009 in the CONTROL, SH, and AH groups, respectively, demonstrating its superiority compared to existing ECG classification methods. In addition, the proposed model is interpretable and can be further extended to clinical applications. Graphical abstract:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.